CGLGX
Price
$21.05
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Net Assets
20.53B
NSOPX
Price
$17.28
Change
+$0.04 (+0.23%)
Updated
Aug 7 closing price
Net Assets
128.01M
Interact to see
Advertisement

CGLGX vs NSOPX

Header iconCGLGX vs NSOPX Comparison
Open Charts CGLGX vs NSOPXBanner chart's image
American Funds Growth and Inc ABLE-F-2
Price$21.05
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets20.53B
North Star Opportunity A
Price$17.28
Change+$0.04 (+0.23%)
VolumeN/A
Net Assets128.01M
CGLGX vs NSOPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGLGX vs. NSOPX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGLGX is a Hold and NSOPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGLGX has more cash in the bank: 20.5B vs. NSOPX (128M). CGLGX pays higher dividends than NSOPX: CGLGX (1.87) vs NSOPX (1.18). CGLGX was incepted earlier than NSOPX: CGLGX (5 years) vs NSOPX (14 years). NSOPX (1.60) is less costly to investors than CGLGX (0.42). NSOPX is a more actively managed with annual turnover of: 21.00 vs. CGLGX (10.00). CGLGX has a lower initial minimum investment than NSOPX: CGLGX (250) vs NSOPX (2500). CGLGX annual gain was more profitable for investors over the last year : 16.54 vs. NSOPX (4.74).
CGLGXNSOPXCGLGX / NSOPX
Total Expense Ratio0.371.5624%
Annual Report Gross Expense Ratio0.421.6026%
Fund Existence5 years14 years-
Gain YTD11.0970.06417,288%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets20.5B128M16,016%
Annual Yield % from dividends1.871.18159%
Returns for 1 year16.544.74349%
Returns for 3 years36.754.54809%
Returns for 5 yearsN/A17.82-
Returns for 10 yearsN/A57.28-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGPKX13.510.10
+0.75%
Baillie Gifford Developed EAFE All Cap K
OAKBX36.97N/A
N/A
Oakmark Equity And Income Investor
MUETX38.18N/A
N/A
MFS Blended Research Core Equity R3
NCGFX67.96N/A
N/A
New Covenant Growth
AFPAX4.15N/A
N/A
DSS AmericaFirst Income A